RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert L. Copeland to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications Robert L. Copeland has written about Antineoplastic Combined Chemotherapy Protocols.
Robert L. Copeland
Connection Strength
0.194
Antineoplastic Combined Chemotherapy Protocols
  1. Knutson SK, Warholic NM, Johnston LD, Klaus CR, Wigle TJ, Iwanowicz D, Littlefield BA, Porter-Scott M, Smith JJ, Moyer MP, Copeland RA, Pollock RM, Kuntz KW, Raimondi A, Keilhack H. Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas. PLoS One. 2014; 9(12):e111840.
    View in: PubMed
    Score: 0.110
  2. Yousuf SJ, Kumar N, Kidwell ED, Copeland RA. Rapidly fatal nasal natural killer/T-cell lymphoma: orbital and ocular adnexal presentations. Orbit. 2011 Mar; 30(2):120-1.
    View in: PubMed
    Score: 0.084
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support